1 month Will Ionis’ (IONS) Wholly-Owned Drugs Drive Future Growth? Zacks
Ionis (IONS) enjoys a diverse revenue stream, including numerous sources of collaborative and R&D revenues. These funds enable it to invest in the development of its wholly-owned pipeline.
California · Pharmaceuticals · Tech · U.S.